Lexicon Pharmaceuticals, Inc.
GPTKB entity
Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Lonnel_Coats
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focusesOn |
drug discovery
development of treatments for human disease |
| gptkbp:foundedYear |
1995
|
| gptkbp:headquartersLocation |
gptkb:The_Woodlands,_Texas,_United_States
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:notableProduct |
gptkb:Xermelo
INPEFA |
| gptkbp:numberOfEmployees |
approximately 200
|
| gptkbp:publiclyTraded |
true
|
| gptkbp:researchInterest |
genomics
small molecule therapeutics |
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:LXRX
|
| gptkbp:website |
https://www.lexpharma.com/
|
| gptkbp:bfsParent |
gptkb:LXRX
gptkb:NASDAQ:LXRX |
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
Lexicon Pharmaceuticals, Inc.
|